Table 2.

Rate of severe hypoglycemia 6 months before CGM use and during 6 months of CGM use

Severe hypoglycemia	6-month control period	6-month CGM use period
Age ≥25 years	38.5 person-years (n = 78)	39.1 person-years (n = 78)
n events (n seizure or loss of consciousness)	13 (2)	9 (2)
n (%) subjects with at least 1 event	9 (12)	8 (10)
Incidence rate (per 100 person-years)	33.7	23.0
Age 15–24 years	35.9 person-years (n = 73)	36.6 person-years (n = 72)
n events (n seizure or loss of consciousness)	8 (3)	3 (2)
n (%) subjects with at least 1 event	7 (10)	3 (4)
Incidence rate (per 100 person-years)	22.3	8.2
Age 8–14 years	30.3 person-years (n = 61)	30.8 person-years (n = 61)
n events (n seizure or loss of consciousness)	8 (1)	4 (2)
n (%) subjects with at least 1 event	6 (10)	3 (5)
Incidence rate (per 100 person-years)	26.4	13.0